Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance
Authors:
- Michal StarkMSMichal Stark
- Eran E. BramEBEran E. Bram
- Martin AkermanMAMartin Akerman
- Yael Mandel-GutfreundYMYael Mandel-Gutfreund
- Yehuda G. AssarafYehuda G. Assaraf
Open Access
- 1 February 2011
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 286 (5) , 3741-3754
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Antiangiogenic and Antitumor Activity of 6-(2-Aminoethyl)Amino-5-Chlorouracil, a Novel Small-Molecule Inhibitor of Thymidine Phosphorylase, in Combination with the Vascular Endothelial Growth Factor-TrapClinical Cancer Research, 2009
- A computational approach for genome-wide mapping of splicing factor binding sitesGenome Biology, 2009
- Identification of Nuclear and Cytoplasmic mRNA Targets for the Shuttling Protein SF2/ASFPLOS ONE, 2008
- Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicingGenome Research, 2007
- Intronic Binding Sites for hnRNP A/B and hnRNP F/H Proteins Stimulate Pre-mRNA SplicingPLOS Biology, 2006
- Complete sequencing and characterization of 21,243 full-length human cDNAsNature Genetics, 2003
- Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humansProceedings of the National Academy of Sciences, 2002
- Reversible cross-linking combined with immunoprecipitation to study RNA–protein interactions in vivoMethods, 2002
- The activity and expression of thymidine phosphorylase in human solid tumoursEuropean Journal of Cancer, 1996
- A serine kinase regulates intracellular localization of splicing factors in the cell cycleNature, 1994